miR‐219 attenuates demyelination in cuprizone‐induced demyelinated mice by regulating monocarboxylate transporter 1
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Remyelination is limited in patients with multiple sclerosis (MS) due to the difficulties in recruiting proliferating oligodendrocyte precursors (OPC s), the inhibition of OPC differentiation and/or maturation, and/or failure in the generation of the myelin sheath. In vitro studies have revealed that miR‐219 is necessary for OPC differentiation and monocarboxylate transporter 1 (MCT 1) plays a vital role in oligodendrocyte maturation and myelin synthesis. Herein, we hypothesized that miR‐219 might promote oligodendrocyte differentiation and attenuate demyelination in a cuprizone (CPZ)‐induced demyelinated model by regulating the expression of MCT 1. We found that CPZ‐treated mice exhibited significantly increased anxiety in the open field test. However, miR‐219 reduced anxiety as shown by an increase in the total distance, the central distance and the mean amount of time spent in the central area. miR‐219 decreased the quantity of OPC s and increased the number of oligodendrocytes and the level of myelin basic protein (MBP) and cyclic nucleotide 3′ phosphodiesterase (CNP) protein. Ultrastructural studies further confirmed that the extent of demyelination was attenuated by miR‐219 overexpression. Meanwhile, miR‐219 also greatly enhanced MCT 1 expression via suppression of oligodendrocyte differentiation inhibitors, Sox6 and Hes5, treatment with the MCT 1 inhibitor α‐cyano‐4‐hydroxycinnamate (4‐CIN) reduced the number of oligodendrocytes and the protein levels of MBP and CNP. Taken together, these results suggest a novel mode of action of miR‐219 via MCT 1 in vivo and may provide a new potential remyelination therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 8×
“The downregulation of oligodendrocyte-specific MCT1 in both the corpus callosum and the optic nerve is associated with axon degeneration, which is presumably one of mechanisms underlying MS (Lee et al., 2012).”
BackgroundInfluentialPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 1×
“It was recently reported that the clinical symptom in MS may be relieved by remyelination (Chang et al., 2002; Hartley et al., 2014; Harlow et al., 2015).”
BackgroundMatsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 1×
“Though the underlying mechanism of oligodendrocyte damage induced by CPZ is not completely understood, mitochondrial disturbance is thought to be the main cause of apoptosis whilst OPCs are not affected or are only marginally affected (Matsushima & Morell, 2001; Benardais et al., 2013).”
BackgroundMonocarboxylate transporters in the central nervous system: distribution, regulation and function
Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744
Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., & Barres, B. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.027 · Cited by 577
MicroRNA-Mediated Control of Oligodendrocyte Differentiation
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T., Xu, X., Mi, Q.-S., Xin, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.018 · Cited by 508 · cited 4×
“A large number of publications in the literature have pointed to a role of miR-219 in OPC differentiation in vitro (Dugas et al., 2010; Zhao et al., 2010; Ebrahimi-Barough et al., 2013; Pusic & Kraig, 2014). miR-219 has also been demonstrated to promote oligodendrocyte formation in the normal chick…”
BackgroundInfluentialGlial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 430 · cited 1×
“Cuprizone is a copper chelating reagent, which when supplemented to normal rodent chow, directly or indirectly causes oligodendroglial cell death with subsequent demyelination (Gudi et al., 2014; El-Etr et al., 2015).”
BackgroundRegulation of Oligodendrocyte Development and Myelination by Glucose and Lactate
Rinholm, J. E., Hamilton, N. B., Kessaris, N., Richardson, W. D., Bergersen, L. H., & Attwell, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3516-10.2011 · Cited by 383 · cited 1×
“Evidence has supported the conclusion that extra lactate could rescue neuron degeneration caused by MCT1 deficiency (Rinholm et al., 2011; Lee et al., 2012; Morrison et al., 2013).”
Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination
Franco-Pons, N., Torrente, M., Colomina, M. T., & Vilella, E. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.01.010 · Cited by 195 · cited 3×
“The open field test was used to evaluate the motor activity and exploration and anxiety in CPZ model mice or other animal models (Franco-Pons et al., 2007; Li et al., 2016; Okuliarova et al., 2016).”
BackgroundMethodXiao, L., Xu, H., Zhang, Y., Wei, Z., He, J., Jiang, W., Li, X., Dyck, L. E., Devon, R. M., Deng, Y., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002064 · Cited by 191 · cited 2×
“…MS (Coghe et al., 2015), and CPZ model mice have severe motor dysfunction (Franco-Pons et al., 2007; Hibbits et al., 2009; Li et al., 2016), an impairment of spatial working memory (Xiao et al., 2008; Adilijiang et al., 2015), and a diminishing of social interaction (Brunet-Gouet & Decety, 2006).”
BackgroundLindner, M., Heine, S., Haastert, K., Garde, N., Fokuhl, J., Linsmeier, F., Grothe, C., Baumgärtner, W., & Stangel, M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00879.x · Cited by 169
Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes
Bénardais, K., Kotsiari, A., Škuljec, J., Koutsoudaki, P. N., Gudi, V., Singh, V., Vulinović, F., Skripuletz, T., & Stangel, M. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9380-9 · Cited by 148
The emerging role of microRNAs in multiple sclerosis
Junker, A., Hohlfeld, R., & Meinl, E. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.179 · Cited by 129 · cited 2×
“In the past several years, great progress has been made in understanding of the posttranscriptional control of gene expression by microRNAs in controlling CNS myelination (Shin et al., 2009; Zhao et al., 2010; Junker et al., 2011; Li & Yao, 2012).”
BackgroundEl-Etr, M., Rame, M., Boucher, C., Ghoumari, A. M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., & Sitruk-Ware, R. (2015) · Glia · doi:10.1002/glia.22736 · Cited by 116
Hibbits, N., Pannu, R., Wu, T. J., & Armstrong, R. C. (2009) · ASN Neuro · doi:10.1042/an20090032 · Cited by 111 · cited 2×
“…is a crucial problem in patient with MS (Coghe et al., 2015), and CPZ model mice have severe motor dysfunction (Franco-Pons et al., 2007; Hibbits et al., 2009; Li et al., 2016), an impairment of spatial working memory (Xiao et al., 2008; Adilijiang et al., 2015), and a diminishing of…”
BackgroundRegulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes
de Faria Jr., O., Cui, Q.-L., Bin, J. M., Bull, S.-J., Kennedy, T. E., Bar-Or, A., Antel, J. P., Colman, D. R., & Dhaunchak, A. S. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00046 · Cited by 54 · cited 1×
“Several microRNAs that induce oligodendrocytes differentiation have been identified, including miR-219, miR-338, miR-138, miR29, and miR-23 (de Faria et al., 2012; Shin et al., 2012).”
Background
Cited by
Monocarboxylate transporters in cancer
Payen, V. L., Mina, E., Van Hée, V. F., Porporato, P. E., & Sonveaux, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.006 · Cited by 644
Molecular Control of Oligodendrocyte Development
Elbaz, B., & Popko, B. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.01.002 · Cited by 293
Osorio-Querejeta, I., Carregal-Romero, S., Ayerdi-Izquierdo, A., Mäger, I., Nash, L. A., Wood, M., Egimendia, A., Betanzos, M., Alberro, A., Iparraguirre, L., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020186 · Cited by 85
Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice
Martin, N. A., Molnar, V., Szilagyi, G. T., Elkjaer, M. L., Nawrocki, A., Okarmus, J., Wlodarczyk, A., Thygesen, E. K., Palkovits, M., Gallyas, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00490 · Cited by 45
MicroRNAs in oligodendrocyte development and remyelination
Ngo, C., & Kothary, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15618 · Cited by 44
Metadata
- Authors
- Liu, S., Ren, C., Qu, X., Wu, X., Dong, F., Chand, Y. K., Fan, H., Yao, R., & Geng, D.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2017-01
- Volume
- 45
- Issue
- 2
- Pages
- 249-259
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2551266034
- Cited by
- 51
- References
- 16
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.